| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 45-50, Copyright © 1994 by Endocrine Society
ARTICLES |
GM Lambert-Messerlian, JE Hall, PM Sluss, AE Taylor, KA Martin, NP Groome, WF Crowley Jr and AL Schneyer
Reproductive Endocrine Unit, Massachusetts General Hospital, Boston 02114.
The endocrine feedback role of dimeric inhibin on FSH secretion from the pituitary has been well established in many species; however, evidence that inhibin is an important endocrine regulator of FSH in the human is more tenuous. One potential explanation for the equivocal data may be that the inhibin immunoassay used most widely in the human is a heterologous assay with an antiserum that exclusively recognizes the inhibin alpha-subunit in both its monomeric form and in inhibin dimers. The aim of the present study was to quantify serum inhibin levels in a variety of fertile and infertile men and women using a new ultrasensitive enzyme-linked immunosorbent assay that is specific for the dimeric form (alpha/beta) only. The specificity of the present assay was demonstrated by the absence of significant cross-reactivity with Mullerian inhibiting substance, transforming growth factor-beta, activin, FSH, LH, hCG, TSH, and hCG alpha and with the alpha-subunit of inhibin. The assay was sensitive to 1 pg/mL, and serial dilutions of human male and female serum samples paralleled the recombinant 32- kilodalton (kDa) dimeric inhibin standard curve. Complete recovery of exogenous recombinant 32-kDa inhibin added to serum was obtained. Mean serum inhibin levels ranged from a low of 5.7 +/- 0.6 pg/mL in the early follicular phase to 49.0 +/- 11.2 pg/mL in the midluteal phase of the normal menstral cycle and were elevated during ovulation induction (1250 pg/mL) and pregnancy (500 pg/mL). Interestingly, mean levels of dimeric inhibin in women with polycystic ovarian syndrome (PCOS) were indistinguishable from normal follicular phase. The most striking observation was the extremely low mean inhibin levels (< 2 pg/mL) found in normal men, GnRH-deficient men before any pulsatile GnRH treatment, and men with Klinefelter's syndrome, all of which were indistinguishable from levels observed in postmenopausal women. These observations in the male raise the possibly that 1) some forms of circulating and bioactive inhibin in the human are not detected by this assay due to either their conformation or the presence of a unique binding protein for endogenous inhibin that does not bind to recombinant 32-kDa inhibin; or 2) dimeric inhibin is not a major endocrine regulator of FSH in the human male. In addition, the relatively high dimeric inhibin levels at midcycle and in the luteal phase of the normal menstrual cycle, after gonadotropin stimulation, and during pregnancy suggest that dimeric inhibin is predominantly produced by dominant follicles, corpora lutea, and placental tissues.
This article has been cited by other articles:
![]() |
D. S. Wachs, M. S. Coffler, P. J. Malcom, and R. J. Chang Comparison of Follicle-Stimulating-Hormone-Stimulated Dimeric Inhibin and Estradiol Responses as Indicators of Granulosa Cell Function in Polycystic Ovary Syndrome and Normal Women J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2920 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, A. E. Taylor, J. Fox, G. M. Messerlian, J. M. Adams, and A. L. Schneyer Follicular Arrest in Polycystic Ovary Syndrome Is Associated with Deficient Inhibin A and B Biosynthesis J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5582 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, J. E. Hall, J. M. Adams, and A. E. Taylor Relationship of Estradiol and Inhibin to the Follicle-Stimulating Hormone Variability in Hypergonadotropic Hypogonadism or Premature Ovarian Failure J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 826 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, P. C. Smith, and A. E. Taylor Evidence of Early Ovarian Aging in Fragile X Premutation Carriers J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4569 - 4574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Dighe, F. J. Hayes, J. Khosravi, U. Bodani, and P. M. Sluss Comparison of Inhibin A Immunoassays: Recommendation for Adoption of Standardized Reporting Clin. Chem., April 1, 2004; 50(4): 767 - 769. [Full Text] [PDF] |
||||
![]() |
M. P. Plevyak, G. M. Lambert-Messerlian, A. Farina, N. P. Groome, J. A. Canick, and H. M. Silver Concentrations of Serum Total Activin A and Inhibin A in Preterm and Term Labor Patients: A Cross-Sectional Study Reproductive Sciences, May 1, 2003; 10(4): 231 - 236. [Abstract] [PDF] |
||||
![]() |
C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. X. Liao, R. K. Moore, F. Otsuka, and S. Shimasaki Effect of Intracellular Interactions on the Processing and Secretion of Bone Morphogenetic Protein-15 (BMP-15) and Growth and Differentiation Factor-9. IMPLICATION OF THE ABERRANT OVARIAN PHENOTYPE OF BMP-15 MUTANT SHEEP J. Biol. Chem., January 31, 2003; 278(6): 3713 - 3719. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y.K. Yong, D. T. Baird, K.J. Thong, A. S. McNeilly, and R. A. Anderson Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation Hum. Reprod., January 1, 2003; 18(1): 35 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, A. E. Taylor, K. A. Martin, and J. E. Hall Serum Inhibin B in Polycystic Ovary Syndrome: Regulation by Insulin and Luteinizing Hormone J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5559 - 5565. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Plant and G. R. Marshall The Functional Significance of FSH in Spermatogenesis and the Control of Its Secretion in Male Primates Endocr. Rev., December 1, 2001; 22(6): 764 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Hayes, N. Pitteloud, S. DeCruz, W. F. Crowley Jr., and P. A. Boepple Importance of Inhibin B in the Regulation of FSH Secretion in the Human Male J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5541 - 5546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S.E. Laven, B. Imani, M. J.C. Eijkemans, F. H. de Jong, and B. C.J.M. Fauser Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility Hum. Reprod., July 1, 2001; 16(7): 1359 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, Z. A. Smith, D. K. Pauler, and J. E. Hall Differential Regulation of Inhibin A and Inhibin B by Luteinizing Hormone, Follicle-Stimulating Hormone, and Stage of Follicle Development J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2531 - 2537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt and A. L. Schneyer Differential Regulation of Inhibin B and Inhibin A by Follicle-Stimulating Hormone and Local Growth Factors in Human Granulosa Cells from Small Antral Follicles J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 330 - 336. [Abstract] [Full Text] |
||||
![]() |
G. M. Lambert-Messerlian, H. M. Silver, F. Petraglia, S. Luisi, I. Pezzani, W. M. Maybruck, W. A. Hogge, K. Hanley-Yanez, J. M. Roberts, L. M. Neveux, et al. Second-Trimester Levels of Maternal Serum Human Chorionic Gonadotropin and Inhibin A as Predictors of Preeclampsia in the Third Trimester of Pregnancy Reproductive Sciences, May 1, 2000; 7(3): 170 - 174. [Abstract] [PDF] |
||||
![]() |
Z. Blumenfeld, I. Avivi, M. Ritter, and J. M. Rowe Preservation of Fertility and Ovarian Function and Minimizing Chemotherapy-Induced Gonadotoxicity in Young Women Reproductive Sciences, September 1, 1999; 6(5): 229 - 239. [Abstract] [PDF] |
||||
![]() |
C. K. Welt, J. M. Adams, P. M. Sluss, and J. E. Hall Inhibin A and Inhibin B Responses to Gonadotropin Withdrawal Depends on Stage of Follicle Development J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2163 - 2169. [Abstract] [Full Text] |
||||
![]() |
N. H. I. Hjollund, T. K. Jensen, J. P. E. Bonde, T. B. Henriksen, A.-M. Andersson, and N. E. Skakkebęk Is glycosylated haemoglobin a marker of fertility? A follow-up study of first-pregnancy planners Hum. Reprod., June 1, 1999; 14(6): 1478 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hall, C. K. Weltand, and D. W. Cramer Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome Hum. Reprod., February 1, 1999; 14(2): 409 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, D. J. McNicholl, A. E. Taylor, and J. E. Hall Female Reproductive Aging Is Marked by Decreased Secretion of Dimeric Inhibin J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 105 - 111. [Abstract] [Full Text] |
||||
![]() |
F. J. Hayes, J. E. Hall, P. A. Boepple, and W. F. Crowley Jr. Differential Control of Gonadotropin Secretion in the Human: Endocrine Role of Inhibin J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1835 - 1841. [Full Text] |
||||
![]() |
N. Di Simone, H. A. Hall, C. Welt, and A. L. Schneyer Activin Regulates {beta}A-Subunit and Activin Receptor Messenger Ribonucleic Acid and Cellular Proliferation in Activin-Responsive Testicular Tumor Cells Endocrinology, March 1, 1998; 139(3): 1147 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, G. Lambert-Messerlian, W. Zheng, W. F. Crowley Jr., and A. L. Schneyer Presence of Activin, Inhibin, and Follistatin in Epithelial Ovarian Carcinoma J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3720 - 3727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Welt, K. A. Martin, A. E. Taylor, G. M. Lambert-Messerlian, W. F. Crowley Jr., J. A. Smith, D. A. Schoenfeld, and J. E. Hall Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2645 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pigny, R. Desailloud, C. Cortet-Rudelli, A. Duhamel, D. Deroubaix-Allard, A. Racadot, and D. Dewailly Serum {alpha}-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1939 - 1943. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |